| (210) | Number of the EPO application | 16788243 |
| (220) | Filing date of the EPO application | 2016.10.14 |
| (80) | EPO patent specification publication (B) | EPB nr. 25/2022, 2022.06.22 |
| (110) | EPO patent number | 3362100 |
| (21) | Number of the application | e 2018 0814 |
| (71) | Name(s) of applicant(s), code of the country | Genentech, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | DRAGOVICH Peter, US;
PEI Zhonghua, US;
PILLOW Thomas, US;
SADOWSKY Jack, US;
CHEN Jinhua, CN;
WAI John, CN; |
| (73) | Name(s) of owner(s), code of the country | GENENTECH Inc., US; |
| (54) | Title of the invention | HINDERED DISULFIDE DRUG CONJUGATES |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 47/64 (2017.01.01); A61K 47/68 (2017.01.01); A61K 38/05 (2006.01.01); A61P 35/00 (2006.01.01); C07D 213/71 (2006.01.01); C07D 233/84 (2006.01.01); C07D 235/28 (2006.01.01); C07D 249/10 (2006.01.01); C07D 257/04 (2006.01.01); C07D 263/58 (2006.01.01); C07D 277/78 (2006.01.01); C07D 471/04 (2006.01.01); C07D 473/34 (2006.01.01); C07D 498/18 (2006.01.01); C07D 521/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.10.31 |
| (30) | Priority | PCT/CN2015/0920, 2015.10.16, WO |
| (86) | International application | PCT/IB2016/056186, 2016.10.14 |
| (87) | International publication | WO 2017/064675, 2017.04.20 |